Our research showed that PF had an influential role in the anti-inflammatory mechanism of MRL/lpr mice, and inhibiting the IRAK1-NF-κB pathway might be a unique and promising treatment strategy for lupus inflammation. Here, NFKB1 is linked to systemic lupus erythematosus.